hepatitis B

Search with Google Search with Bing
Information
Disease name
hepatitis B
Disease ID
DOID:2043
Description
"A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus, which is transmitted_by sexual contact, blood transfusions, or fomites like needles or syringes. The infection has_symptom fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, clay-colored bowel movements, joint pain, and jaundice." [url:http\://en.wikipedia.org/wiki/Hepatitis_B#Transmission, url:http\://www.cdc.gov/hepatitis/HBV/index.htm, url:http\://www.cdc.gov/hepatitis/Resources/Professionals/PDFs/ABCTable.pdf]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
HLA-DPB1 6 33,075,990 33,089,696 262
TSBP1 6 32,292,698 32,371,879 128
HLA-DPA1 6 33,064,569 33,080,710 80
HLA-DRA 6 32,439,887 32,445,046 46
BTNL2 6 32,393,339 32,407,181 28
PSORS1C1 6 31,114,800 31,140,092 22
NOTCH4 6 32,194,843 32,224,067 16
ATP6V1G2-DDX39B 6 31,530,219 31,546,582 16
DDX39B 6 31,530,219 31,542,448 14
HLA-DQA2 6 32,741,391 32,747,198 12
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02849132 Active, not recruiting Phase 4 Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients January 2016 December 2025
NCT04778904 Active, not recruiting Phase 1/Phase 2 First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV December 22, 2020 February 21, 2023
NCT02766933 Active, not recruiting Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study May 2016 December 2024
NCT04710641 Active, not recruiting Phase 2 Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone January 1, 2022 May 1, 2025
NCT05768061 Active, not recruiting HBV Reactivation in Anti CD20 Treatment December 16, 2021 December 2023
NCT06379334 Active, not recruiting Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population December 6, 2020 December 6, 2026
NCT02344498 Active, not recruiting Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa January 2015 December 2024
NCT05541081 Active, not recruiting N/A Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe January 12, 2023 April 2024
NCT04193189 Active, not recruiting Phase 3 B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B December 14, 2020 July 26, 2024
NCT04947475 Active, not recruiting N/A Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community January 1, 2017 July 31, 2024
NCT01796457 Active, not recruiting HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B March 2013 December 1, 2024
NCT03489239 Active, not recruiting Phase 3 Entecavir to TAF Switch November 16, 2017 September 16, 2020
NCT03343431 Active, not recruiting Phase 3 Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection August 2, 2018 January 31, 2025
NCT01298037 Active, not recruiting HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B February 1, 2011 December 1, 2024
NCT00097006 Completed Retrovirus Epidemiology Donor Study-II (REDS-II) September 2004 September 2009
NCT00100633 Completed Phase 1/Phase 2 Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People December 2004 October 2007
NCT00106964 Completed Phase 4 Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth January 2004 June 2009
NCT00107042 Completed Phase 2 Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths February 2004 July 2008
NCT00114361 Completed Phase 3 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection March 2005 April 2010
NCT00124241 Completed Phase 2 An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B November 2005
NCT00125762 Completed N/A FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy March 2005 October 1, 2008
NCT00127959 Completed Phase 4 Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection March 2004 August 2006
NCT00128544 Completed Phase 2 Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B May 2005 May 2007
NCT00133445 Completed Phase 2 Pentavalent DTaP-Hep B-IPV December 2005 August 2006
NCT00136604 Completed Phase 3 Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m January 22, 2006 April 23, 2006
NCT00138268 Completed Pilot Study Freeze and Transport Immune Cells February 2005
NCT00142740 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 October 2005 June 2008
NCT00146835 Completed Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine April 2003 June 2006
NCT00150098 Completed N/A Project UNITY - HIV Risk Reduction and Vaccine Education Interventions February 2005 October 2010
NCT00155155 Completed Studies of Immune Responses in Patients With Chronic Hepatitis B May 2005
NCT00158717 Completed Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. April 2003 April 2006
NCT00158756 Completed Phase 3 Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants September 12, 2005 November 23, 2006
NCT00158808 Completed Phase 2 Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths January 2005 April 2005
NCT00168194 Completed Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History December 2004 December 2009
NCT00169442 Completed Phase 3 Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants February 10, 2005 March 10, 2006
NCT00169858 Completed Phase 4 Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections September 1995 May 2012
NCT00175435 Completed Phase 1/Phase 2 Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator August 2005 April 2007
NCT00186836 Completed Phase 4 Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients November 2004 November 2006
NCT03511794 Completed Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant April 13, 2018 February 2, 2022
NCT00000583 Completed Phase 3 Hepatitis B Vaccine Clinical Trial November 1978 June 1980
NCT00000654 Completed Phase 2 The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU February 1993
NCT00001712 Completed Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan February 1998 October 2005
NCT00004850 Completed Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection March 15, 1991
NCT00013702 Completed Phase 2 Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients March 2001 February 2004
NCT00013871 Completed N/A Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs November 2004
NCT00023309 Completed Phase 2 Lamivudine and Adefovir to Treat Chronic Hepatitis B August 2001 August 2013
NCT00033163 Completed Phase 2 A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV May 2005
NCT00051038 Completed Phase 2/Phase 3 Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients September 2002 October 2005
NCT00059267 Completed Prevention of Recurrent Hepatitis B After Liver Transplantation March 2001 November 2007
NCT00065507 Completed Phase 3 Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation August 2003 May 2013
NCT00092469 Completed Phase 3 Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) March 2002 August 2003
NCT00096785 Completed Phase 3 Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection December 2004 April 2008
NCT01251276 Completed Phase 3 Hepatitis B Challenge Dose in Adults (V232-059-10) November 30, 2010 April 12, 2011
NCT01259453 Completed Phase 4 Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules May 2003 August 2006
NCT01263587 Completed Hepatitis B Research Network Adult Cohort Study December 2010 June 9, 2021
NCT01263600 Completed Hepatitis B Research Network Pediatric Cohort Study (HBRN) December 2010 June 9, 2021
NCT01300234 Completed Phase 3 Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) March 30, 2011 December 6, 2016
NCT01317784 Completed N/A Behavioral Science Aspects of Rapid Test Acceptance May 2011 August 2014
NCT01329419 Completed HEPSERA Post Marketing Surveillance August 2004 February 2010
NCT01333813 Completed Phase 4 Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children April 26, 2011 September 28, 2011
NCT01334567 Completed Phase 2 Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan August 2010 December 2013
NCT01337479 Completed A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials February 2003 September 2010
NCT01349283 Completed Phase 3 Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns May 2011 November 2013
NCT01350648 Completed Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection August 23, 2011
NCT01353703 Completed Phase 3 Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine April 16, 2012 February 25, 2013
NCT01357720 Completed Phase 4 Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination May 2011 September 2011
NCT01358825 Completed Phase 4 Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ May 30, 2011 July 15, 2011
NCT01362517 Completed Phase 3 Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B April 2010 April 2011
NCT01368497 Completed Phase 3 Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection September 2012 December 23, 2016
NCT01369212 Completed Phase 3 Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B November 2012 March 8, 2021
NCT01427868 Completed Phase 1 Bioequivalence of LB80380 Free Base and Maleate Salt Tablets September 2010 December 2010
NCT01444781 Completed Phase 3 Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants September 2011 October 2013
NCT01453348 Completed Phase 3 Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine October 2011 January 2012
NCT01453998 Completed Phase 2 Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) October 14, 2011 November 12, 2012
NCT01457495 Completed Phase 2 Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly September 1998 September 1999
NCT01457508 Completed Phase 3 Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately January 1999 March 2000
NCT01457547 Completed Phase 4 Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course October 2003 May 2005
NCT01457560 Completed Phase 3 Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine February 2000 April 2001
NCT01463683 Completed Phase 3 Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062) November 29, 2011 November 6, 2012
NCT01470287 Completed Phase 3 Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age December 2011 April 2012
NCT01500265 Completed Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus December 2011 December 2015
NCT01513850 Completed Phase 3 A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients October 2010 March 2014
NCT01574521 Completed Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) January 2008 December 2011
NCT01580202 Completed Phase 3 Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine April 2012 June 2017
NCT01590615 Completed Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy April 26, 2012 April 4, 2017
NCT01590641 Completed Phase 1 A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B April 2012 October 2013
NCT01590654 Completed Phase 1 A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection April 2012 December 2013
NCT01606163 Completed Phase 1 Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection August 2012 December 2013
NCT01623778 Completed Optimization of Antiviral Therapy of Chronic HBV Infection January 2009 December 2011
NCT01627340 Completed Phase 4 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus July 24, 2012 December 18, 2013
NCT01681420 Completed N/A Improving Blood Safety and HIV Testing in Brazil August 1, 2012 January 31, 2015
NCT01732354 Completed Study for Consolidation Period of Chronic Hepatitis B September 2012 April 18, 2018
NCT01767597 Completed N/A Application of HBV Rapid Tests as a Tool for Wide-Use Screening February 2012 January 2013
NCT01772121 Completed Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India May 2012 October 2012
NCT01777074 Completed Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians November 2009 April 2012
NCT01777295 Completed Phase 2 Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System February 25, 2013 September 13, 2016
NCT01782794 Completed Acceptability of Hepatitis B Vaccination in General Population May 2009 June 2012
NCT01790633 Completed N/A Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests February 2013 October 2013
NCT01810835 Completed Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. November 2011 November 2013
NCT01821547 Completed Phase 4 New Methods to Measure the Immune Response to Hepatitis B Vaccine March 2013 May 2016
NCT01844414 Completed N/A UCLA-Amity Parolee Health Promotion Study February 2010 May 2015
NCT01847430 Completed Phase 4 Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder July 19, 2013 February 21, 2014
NCT01856413 Completed Phase 3 A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant December 2012 September 2014
NCT01861613 Completed Phase 4 Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students September 2009
NCT01863589 Completed Drug Use Investigation for HEPSERA (Adefovir) Tablet February 2005 July 2012
NCT01878435 Completed N/A Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya October 2013 February 2016
NCT01884415 Completed Phase 3 Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis September 7, 2012 December 2017
NCT01896596 Completed Phase 4 Hepatitis B Vaccination in Infants July 2013 April 2017
NCT01917357 Completed Phase 3 A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject September 2013 April 2014
NCT01924455 Completed HBV-HIV Coinfection Research Network April 2014 March 31, 2019
NCT01931644 Completed At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions July 2013 April 2024
NCT01948193 Completed Phase 3 Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth February 2014 June 2015
NCT01962155 Completed Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters August 2013 September 2016
NCT01970254 Completed Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy June 24, 2013 July 19, 2022
NCT01983540 Completed Phase 3 Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination October 2013 December 2015
NCT01988753 Completed Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases October 2013 June 2016
NCT01999699 Completed Phase 1 A Study of the Immune Response to Heplisav in Healthy Older Adults November 2013 March 2015
NCT02003703 Completed Phase 3 Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . May 2015 December 2018
NCT02012998 Completed Phase 3 Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA January 2014 February 2015
NCT02025842 Completed Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma January 2000 December 2013
NCT02032160 Completed N/A A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines May 2014 February 2016
NCT02040636 Completed Phase 2 Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis January 1999 May 2000
NCT02044523 Completed Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound January 2014 June 2018
NCT02052661 Completed Phase 4 This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa February 18, 2014 September 23, 2014
NCT02055365 Completed N/A Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers February 18, 2014 January 6, 2015
NCT02057263 Completed Phase 1 The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults April 2014 February 2016
NCT02094833 Completed Phase 3 DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants March 2014 November 2016
NCT02096263 Completed Phase 3 Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants April 16, 2014 November 13, 2015
NCT02108444 Completed Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients January 2007 March 2014
NCT02139722 Completed N/A Patient-Centered Care and Asian Americans January 2, 2014 July 30, 2017
NCT02152709 Completed Phase 3 Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine November 2008 October 2010
NCT02153320 Completed Phase 1 Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers September 5, 2005 October 28, 2005
NCT02169674 Completed Phase 4 Hepatitis B Booster Study in Adolescence September 2014 May 2016
NCT02186977 Completed Phase 1 Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID March 2016 December 2016
NCT02203357 Completed Phase 4 A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults March 2014 December 2016
NCT02247752 Completed N/A Follow-up of HBsAg Inactive Carriers Study September 16, 2014 February 4, 2022
NCT02323308 Completed Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination December 2010 June 2014
NCT02324218 Completed This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age October 2014 January 2015
NCT02366286 Completed Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants November 2010 October 5, 2017
NCT02402699 Completed Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan December 15, 2015 March 23, 2017
NCT02421666 Completed N/A A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV September 2014 January 31, 2018
NCT02428491 Completed Phase 3 Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth April 20, 2015 January 11, 2017
NCT02431312 Completed Phase 1 Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects January 12, 2015 May 22, 2018
NCT02434848 Completed Phase 2/Phase 3 A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses July 23, 2015 June 10, 2022
NCT02445703 Completed Phase 4 Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine May 2014 June 2016
NCT02496897 Completed Phase 1 Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B July 2015 June 5, 2018
NCT02511743 Completed Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection April 2015 November 2015
NCT02540538 Completed Phase 1 Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders September 2015 July 2016
NCT02548325 Completed Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study June 1, 2014 July 2017
NCT02584543 Completed Phase 4 A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) October 2015 August 25, 2016
NCT02596438 Completed Thousand Asian American Study October 1, 2012 September 30, 2017
NCT02610348 Completed N/A Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age November 2015 March 2016
NCT02647281 Completed Phase 1 First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects December 17, 2015 January 3, 2017
NCT02697474 Completed Phase 3 Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine. February 2016 January 2017
NCT02713620 Completed Phase 4 Hepatitis B Vaccination in HIV-infected Adults January 2015 January 2016
NCT02732054 Completed Phase 4 Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts March 2015 February 2016
NCT02749864 Completed Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) July 1, 2015 April 1, 2017
NCT02751996 Completed Phase 2 A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV May 2016 February 10, 2020
NCT02759354 Completed Phase 3 Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) April 26, 2016 August 1, 2016
NCT02760537 Completed N/A Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans April 2013 October 2014
NCT02782247 Completed Dynamic Liver Tests in Liver Disease May 2016 October 2022
NCT02791386 Completed Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy November 22, 2016 October 30, 2017
NCT02798952 Completed Phase 4 A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy August 23, 2016 July 5, 2017
NCT02817451 Completed Phase 3 DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants July 14, 2016 February 22, 2019
NCT02850848 Completed Phase 4 Pharmacokinetics of Two Formulations of Entecavir December 2015 February 2016
NCT02853929 Completed Phase 4 Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery September 19, 2016 March 19, 2019
NCT02858440 Completed Phase 3 A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia September 13, 2016 November 13, 2018
NCT02909023 Completed Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured July 2016 November 2016
NCT02981602 Completed Phase 2 Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection February 24, 2017 December 26, 2019
NCT02985450 Completed A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada August 2016 January 2021
NCT02995005 Completed Phase 1/Phase 2 Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus May 24, 2018 January 31, 2023
NCT03020745 Completed Phase 2 A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects February 14, 2017 November 6, 2019
NCT03083158 Completed Phase 4 Immunity to Hepatitis B Vaccine March 6, 2017 February 1, 2018
NCT03088995 Completed Pilot Study of HIV and Hepatitis B and C Screening in Surgery April 1, 2017 December 1, 2017
NCT03149874 Completed N/A Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients December 1, 2014 May 1, 2017
NCT03155984 Completed Optimizing HBV Management During Anti-CD20 Antibodies October 1, 2013 December 1, 2017
NCT03181113 Completed Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy May 18, 2016 September 21, 2020
NCT03208101 Completed Phase 1 A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults July 3, 2017 December 21, 2017
NCT03248622 Completed Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection June 3, 2017 May 28, 2019
NCT03285620 Completed Phase 1 A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants September 7, 2017 November 14, 2018
NCT03307902 Completed Phase 2/Phase 3 ID HBV Vaccination With Imiquimod in OBI October 1, 2016 July 31, 2019
NCT03312023 Completed Phase 2 Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection February 1, 2018 June 30, 2021
NCT03345498 Completed Entecavir for Decompensated HBV Cirrhosis January 1, 2017 December 31, 2018
NCT03361956 Completed Phase 2 An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection February 13, 2018 August 13, 2020
NCT03365947 Completed Phase 1/Phase 2 Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) March 27, 2018 April 23, 2020
NCT03410953 Completed Phase 4 Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines April 13, 2018 October 31, 2019
NCT03415672 Completed Phase 2 Hepatitis B Vaccine for Non-responders October 11, 2017 January 9, 2019
NCT03425513 Completed Hepatitis B Virus Prevalence and Risk Factors in Belgium May 12, 2017 November 27, 2017
NCT03426618 Completed A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B January 12, 2018 March 13, 2019
NCT03482388 Completed N/A Crowdsourcing to Promote HBV and HCV Testing in China May 9, 2018 June 9, 2018
NCT00000580 Completed Phase 3 Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin November 1975 June 1986
NCT03535779 Completed Characterisation of Human B Cell Maturation in Response to Vaccination March 6, 2017 March 13, 2018
NCT03546530 Completed N/A The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients June 1, 2016 January 2017
NCT03567382 Completed Phase 4 Arresting Vertical Transmission of Hepatitis B Virus September 24, 2018 August 15, 2020
NCT03577938 Completed N/A Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment January 10, 2019 June 30, 2021
NCT03579576 Completed Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar December 20, 2017 June 30, 2019
NCT03596697 Completed Phase 1 A Study in Healthy Volunteers July 9, 2019 June 4, 2021
NCT03620474 Completed Phase 1/Phase 2 Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis July 24, 2018 February 28, 2022
NCT03702998 Completed Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population December 1, 2018 January 16, 2023
NCT03797014 Completed Phase 4 B/F/TAF Switch Study for HIV-HBV Coinfection April 30, 2019 May 5, 2023
NCT03870061 Completed N/A Evaluation of an Infant Immunization Encouragement Program in Nigeria July 1, 2018 February 20, 2020
NCT03897946 Completed Phase 4 Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC August 20, 2019 February 5, 2021
NCT03931239 Completed N/A The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks March 1, 2018 July 30, 2018
NCT03977987 Completed Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission January 1, 2011 December 30, 2018
NCT04029454 Completed N/A Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule October 19, 2020 December 15, 2023
NCT04075201 Completed Phase 1 Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) July 7, 2019 July 25, 2021
NCT04083157 Completed Phase 2/Phase 3 Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients August 12, 2019 December 30, 2021
NCT04109625 Completed N/A Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening October 21, 2019 May 13, 2022
NCT04114890 Completed Phase 2 Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. January 8, 2021 September 29, 2023
NCT04177485 Completed N/A Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda February 1, 2016 December 4, 2017
NCT04179786 Completed Phase 4 A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ November 1, 2015 April 25, 2017
NCT04188223 Completed Phase 1 Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children December 3, 2019 July 16, 2020
NCT04199715 Completed Phase 1 Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients December 3, 2019 January 20, 2022
NCT04209400 Completed Phase 3 Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B® April 18, 2014 April 20, 2015
NCT04240678 Completed N/A The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening January 1, 2016 July 1, 2021
NCT04264312 Completed Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria July 28, 2017 January 10, 2020
NCT04297917 Completed Phase 1 First in Human Study of ChAdOx1-HBV February 10, 2019 May 26, 2022
NCT04309526 Completed Phase 1 Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects March 18, 2020 October 13, 2020
NCT04325542 Completed N/A Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania October 1, 2014 February 1, 2018
NCT04363411 Completed N/A Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections October 25, 2018 October 22, 2019
NCT04366492 Completed N/A HBV/HCV/HIV in Belgian Prisons April 1, 2019 March 31, 2020
NCT04449029 Completed Phase 2 A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) July 27, 2020 March 18, 2022
NCT04490499 Completed Phase 3 A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013) September 2, 2020 December 29, 2020
NCT04503993 Completed N/A Healthy Planet Hepatitis B February 25, 2020 December 31, 2021
NCT04531098 Completed Phase 3 A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults March 2, 2006 December 31, 2008
NCT04544956 Completed Phase 2 A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B October 6, 2020 November 30, 2023
NCT04585789 Completed Phase 2 A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection March 11, 2021 January 9, 2024
NCT04659005 Completed N/A Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening February 1, 2021 February 28, 2022
NCT04676724 Completed Phase 2 Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) January 28, 2021 February 17, 2023
NCT04783753 Completed Phase 1 Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects November 5, 2020 July 9, 2021
NCT04868981 Completed Phase 1 Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets May 31, 2021 March 14, 2022
NCT04870021 Completed Phase 4 Hepatitis B Birth Dose for Newborns March 15, 2015 June 30, 2016
NCT04893616 Completed N/A Cameroon HepB Birth Dose Feasibility Pilot June 10, 2021 December 31, 2021
NCT04906109 Completed Phase 1 Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects July 12, 2021 October 5, 2021
NCT04971928 Completed Phase 1 Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment September 7, 2021 May 12, 2022
NCT05002907 Completed Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) January 1, 2018 December 23, 2019
NCT05127187 Completed Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center February 8, 2022 December 7, 2022
NCT05275465 Completed Phase 1 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers May 3, 2022 December 29, 2022
NCT05472051 Completed Health and Migration Trajectories of Housekeepers in Bamako February 28, 2022 June 22, 2023
NCT05791851 Completed Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders October 23, 2019 June 14, 2022
NCT06147895 Completed Phase 1 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine September 17, 2021 September 25, 2023
NCT06360484 Completed Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus June 1, 2022 September 10, 2022
NCT00197119 Completed Phase 3 Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years May 2004 June 2004
NCT00197158 Completed Phase 4 Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response March 2005 December 2005
NCT00197171 Completed Phase 3 Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine September 2003 December 2003
NCT00197184 Completed Phase 3 Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared November 1, 2003 March 10, 2004
NCT00197275 Completed Phase 3 Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants February 2006 November 2006
NCT00219453 Completed Phase 1 Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination October 2004 January 2006
NCT00222664 Completed Phase 4 Qidong Hepatitis B Intervention Study September 1983 December 2004
NCT00228917 Completed Phase 3 Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children June 16, 2005 January 20, 2006
NCT00230061 Completed Phase 4 Hepatitis B Vaccination in HIV-infected Persons April 2004 February 2010
NCT00230477 Completed Phase 4 Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT April 2003 August 2007
NCT00240500 Completed Phase 4 Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers October 2003 November 2007
NCT00240526 Completed Phase 4 LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers October 2003 March 2010
NCT00240539 Completed Phase 4 Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg) October 2003 July 2008
NCT00244374 Completed N/A A Randomized Trial of Vaccine Adherence in Young Injection Drug Users August 2004 June 2008
NCT00275652 Completed Phase 3 A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. June 2004 August 2007
NCT00289718 Completed Phase 3 Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule November 1, 2004 March 2, 2005
NCT00289731 Completed Phase 4 Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc November 24, 2003 December 21, 2004
NCT00289744 Completed Phase 3 Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule February 16, 2004 April 15, 2009
NCT00289770 Completed Phase 3 Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults November 1, 2004 December 20, 2004
NCT00289796 Completed Phase 2 Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine July 2004 December 2006
NCT00290303 Completed Phase 3 Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants May 2004 March 2005
NCT00291941 Completed Phase 3 A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. February 2006 March 2007
NCT00291954 Completed Phase 3 Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination March 2006 October 2007
NCT00291967 Completed Phase 2 Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants November 2002
NCT00291980 Completed Phase 3 A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. March 2006 October 2007
NCT00303316 Completed Phase 3 Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants February 2006 September 2007
NCT00307567 Completed Phase 2 Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 November 2005 March 2006
NCT00313911 Completed Phase 3 Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. July 2006 February 2008
NCT00315055 Completed Phase 3 Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule July 2006 February 2008
NCT00316147 Completed Phase 3 Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules December 2005 August 2006
NCT00317135 Completed Phase 3 Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. December 11, 2003 October 23, 2004
NCT00317161 Completed Phase 3 Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. August 2004 April 2005
NCT00317174 Completed Phase 2 A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. July 2003 April 2004
NCT00317187 Completed Phase 3 Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. June 8, 2004 January 16, 2005
NCT00320463 Completed Phase 3 Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants April 2006 January 2007
NCT00322361 Completed Phase 2 Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) May 2006 July 2007
NCT00329576 Completed Phase 4 Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine May 2006 August 2006
NCT00332566 Completed Phase 3 Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib June 2006 October 2006
NCT00335881 Completed Phase 4 Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib June 2006 November 2006
NCT00343889 Completed Phase 3 Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine August 2006 April 2008
NCT00343915 Completed Phase 3 Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs April 21, 2004 January 10, 2008
NCT00348881 Completed Phase 3 Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants June 2006 June 2008
NCT00352963 Completed Phase 3 Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). September 30, 2003 July 16, 2004
NCT00356564 Completed Phase 4 Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib July 2006 December 2006
NCT00362336 Completed Phase 3 Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV August 2006 August 2009
NCT00362427 Completed Phase 2 Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® August 2006 March 2009
NCT00362635 Completed Phase 3 Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection August 2006
NCT00362674 Completed Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial June 2005
NCT00366366 Completed Phase 3 To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines September 2001 September 2002
NCT00376779 Completed Phase 2 Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age October 2006 May 2007
NCT00380614 Completed Phase 4 A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B January 2002 March 2005
NCT00381992 Completed Risk Assessment of Long-Haul Truck Drivers September 2005 March 2010
NCT00383227 Completed Phase 3 Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years December 1999 November 2000
NCT00383383 Completed Phase 3 Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years December 1999
NCT00383591 Completed Phase 3 Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years March 2002 January 2004
NCT00391638 Completed Phase 2/Phase 3 Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients January 2007 October 2012
NCT00393523 Completed Phase 3 Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) September 2006 June 2008
NCT00401336 Completed N/A Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging November 2006 March 2013
NCT00401531 Completed Phase 3 Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants October 2006 August 2008
NCT00404651 Completed Phase 3 Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants November 2006 July 2008
NCT00411697 Completed Phase 4 Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge December 2006 May 2007
NCT00412529 Completed Phase 3 Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B December 2006
NCT00414050 Completed Phase 3 A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) October 6, 2006 October 24, 2007
NCT00426712 Completed Phase 1 Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients January 2006 March 2008
NCT00429481 Completed Phase 2 Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants January 2001 April 2003
NCT00432042 Completed Phase 3 Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) January 12, 2007 March 27, 2008
NCT00435812 Completed Phase 3 Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine December 2006 March 2008
NCT00440531 Completed Phase 3 Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) November 2006 November 2007
NCT00441012 Completed Phase 3 Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) December 2006 June 2008
NCT00445185 Completed Phase 3 Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™ March 2007 November 2009
NCT00456625 Completed Phase 4 Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. April 2007 January 2008
NCT00463437 Completed Phase 3 Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines April 25, 2007 June 14, 2008
NCT00473668 Completed Phase 3 Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib June 1, 2007 January 30, 2008
NCT00480116 Completed Phase 3 Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule January 2008 April 2008
NCT00493506 Completed N/A ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency May 2006 September 2006
NCT00501124 Completed Phase 4 Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV May 2007
NCT00511095 Completed Phase 2 Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine June 2007 March 2008
NCT00514709 Completed Phase 3 Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants September 2007 April 2009
NCT00516945 Completed N/A A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers September 2004 June 2008
NCT00524576 Completed Phase 4 Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine November 28, 2007 May 14, 2008
NCT00534833 Completed Phase 3 Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ September 2007 March 2009
NCT00562783 Completed Phase 2 A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis January 2005 May 2006
NCT00603252 Completed Phase 4 Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults January 2008 June 2008
NCT00611559 Completed Phase 4 Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children February 14, 2008 June 25, 2008
NCT00617812 Completed Phase 4 Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine March 2008 May 2009
NCT00619502 Completed Phase 3 Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants December 2007 July 2008
NCT00627458 Completed Phase 2 Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine February 1, 2008 August 18, 2008
NCT00629486 Completed N/A Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma January 2007 May 2008
NCT00644761 Completed Phase 2 PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients February 2004 May 2005
NCT00645294 Completed Phase 1/Phase 2 Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV February 2003 August 2003
NCT00654901 Completed Phase 3 Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ March 2008 July 2009
NCT00657657 Completed Phase 4 Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine April 2008 August 2008
NCT00662545 Completed Phase 4 Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection April 2008 May 2010
NCT00670839 Completed Phase 3 Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) May 2008 February 2013
NCT00674908 Completed Phase 4 Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine March 2008 May 2009
NCT00684671 Completed Phase 4 Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination May 26, 2008 November 3, 2008
NCT00693186 Completed Phase 3 A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA October 2008 March 2010
NCT00696891 Completed Phase 3 Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults June 1997
NCT00696917 Completed Phase 3 Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y April 1999
NCT00697125 Completed Phase 2 Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants June 1993 July 1994
NCT00697216 Completed Phase 3 Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). March 1997
NCT00697229 Completed Phase 2 Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules September 1992 December 1998
NCT00697242 Completed Phase 3 Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults January 1994 November 1995
NCT00697554 Completed Phase 3 Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age January 2000
NCT00697749 Completed Phase 3 Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype April 1999 January 2000
NCT00697775 Completed Phase 2 Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents March 1998
NCT00697840 Completed Phase 3 Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B June 1995 January 1996
NCT00697853 Completed Phase 2 Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults November 1998
NCT00697866 Completed Phase 3 Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control August 2000
NCT00697931 Completed Phase 3 Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders May 1997 June 1998
NCT00697970 Completed Phase 3 Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine November 1993 April 1995
NCT00698061 Completed Phase 3 Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y November 1999 May 2001
NCT00698087 Completed Phase 3 Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B January 1995 February 1996
NCT00698555 Completed Phase 2 Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y March 1997
NCT00698906 Completed Phase 2 Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y June 1997
NCT00699231 Completed Phase 1 Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients February 1992 December 1992
NCT00704106 Completed Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders May 2008 October 2011
NCT00722332 Completed Phase 4 Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients February 2008 October 2013
NCT00737568 Completed Phase 3 Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine September 2008 February 2015
NCT00744289 Completed N/A Hepatitis B Acceptability and Vaccination Incentive Trial September 2008 May 2011
NCT00753649 Completed Phase 4 Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants September 23, 2008 March 12, 2013
NCT00760721 Completed Phase 3 Increasing Hepatitis B Screening Among Korean Church Attendees September 2006 August 2012
NCT00774995 Completed Phase 4 Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. November 2008 June 2010
NCT00782158 Completed Hepatitis B and HIV Co-Infection in Patients in Uganda October 27, 2008 December 14, 2018
NCT00792610 Completed N/A The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines August 2007 February 2009
NCT00805389 Completed Phase 2 Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine December 15, 2008 July 14, 2011
NCT00831753 Completed Phase 3 Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants May 2008 November 2009
NCT00875485 Completed Phase 4 Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ May 1, 2009 July 1, 2014
NCT00879827 Completed Phase 3 Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants September 2000 May 2001
NCT00880477 Completed Phase 3 Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine January 2001 November 2002
NCT00881036 Completed Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients August 2006 July 2015
NCT00926146 Completed N/A Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV July 2009 February 2015
NCT00926757 Completed Phase 4 Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B April 2009 November 2012
NCT00946010 Completed Investigation of Hepatitis B and Hepatitis C in Taiwan April 2008 January 2011
NCT00970307 Completed Phase 2 Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age August 13, 2009 January 27, 2010
NCT00984139 Completed Phase 4 Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination October 12, 2009 April 7, 2010
NCT00994773 Completed Phase 1 Simvastatin for the Treatment of Chronic Hepatitis B December 2009 December 2011
NCT00998426 Completed Phase 4 Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients October 2009 December 2011
NCT01000324 Completed Phase 4 Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult November 6, 2009 July 25, 2014
NCT01018381 Completed N/A Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection June 2006 November 2009
NCT01037114 Completed Phase 4 Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult January 27, 2010 February 28, 2014
NCT01046799 Completed Phase 3 Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir March 2008 October 2014
NCT01050881 Completed Notification of Donors With Positive Microbiology Markers March 2010 November 2010
NCT01074645 Completed Phase 4 Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure November 2007 October 2009
NCT01090453 Completed Phase 2 Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants May 17, 2010 October 11, 2011
NCT01105559 Completed Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine April 2010 December 2011
NCT01106092 Completed Phase 2 Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers May 13, 2010 September 2, 2010
NCT01124591 Completed Phase 2 Brief Intervention for Drug Misuse in the Emergency Department June 2010 December 2014
NCT01125696 Completed Phase 2 Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV May 2012 August 2018
NCT01131065 Completed Phase 3 Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients July 2010 June 2014
NCT01138098 Completed Phase 4 Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children June 7, 2010 November 26, 2010
NCT01146808 Completed Phase 1/Phase 2 Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver March 2006 September 2012
NCT01163240 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B June 2009
NCT01171989 Completed Phase 2 Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose August 18, 2010 December 3, 2010
NCT01177722 Completed Phase 3 A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants August 2010 December 2011
NCT01182311 Completed Duration of Long-term Immunity After Hepatitis B Virus Immunization September 8, 2010 December 9, 2020
NCT01203319 Completed Phase 2/Phase 3 The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines November 2006 March 2011
NCT01248884 Completed Phase 2 Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) December 9, 2010 January 5, 2012
NCT02699736 Enrolling by invitation EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV January 1994 December 2030
NCT04984772 Enrolling by invitation Prospective Cohort of HIV/HBV-coinfected Patients in Europe October 2, 2001 December 31, 2030
NCT00096811 No longer available Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program September 2003 August 2008
NCT06058286 Not yet recruiting N/A MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia October 1, 2023 December 31, 2024
NCT05102838 Not yet recruiting Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C November 1, 2021 March 31, 2026
NCT05692505 Not yet recruiting Multicenter Performance Study of QuadQuik Invitro Diagnostic Device April 1, 2023 June 1, 2023
NCT06368466 Not yet recruiting N/A A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites April 30, 2024 September 1, 2024
NCT05952596 Not yet recruiting Phase 1 A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults July 17, 2023 March 31, 2024
NCT05457946 Not yet recruiting Phase 2/Phase 3 Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series April 1, 2023 September 30, 2025
NCT06421259 Not yet recruiting Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy. May 20, 2024 May 20, 2026
NCT06422767 Not yet recruiting Phase 1 Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers June 3, 2024 October 8, 2024
NCT05690607 Not yet recruiting Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs) January 23, 2023 January 22, 2024
NCT05394623 Not yet recruiting Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study) November 1, 2022 July 1, 2023
NCT05483894 Not yet recruiting Phase 2 Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial August 1, 2022 January 31, 2025
NCT05768737 Not yet recruiting Awareness of Osteoporosis in Patients With Hepatitis B Infection August 1, 2023 August 1, 2024
NCT02779465 Not yet recruiting Phase 4 Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma June 2016 December 2026
NCT06316492 Not yet recruiting A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses August 1, 2024 June 1, 2026
NCT06368479 Recruiting N/A Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings March 20, 2024 July 1, 2024
NCT05446532 Recruiting Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes June 15, 2022 December 31, 2022
NCT05442372 Recruiting Prevalence of HBV in Pregnancy June 15, 2022 April 15, 2023
NCT05404919 Recruiting Phase 2 Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates September 6, 2022 August 2032
NCT05705427 Recruiting Phase 4 The COMBAT HBV Feasibility Trial August 17, 2023 June 2025
NCT00001971 Recruiting Evaluation of Patients With Liver Disease May 27, 1992
NCT05957380 Recruiting Phase 4 Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients March 20, 2023 November 30, 2024
NCT05977283 Recruiting HBsAg Declined Patients Follow-up Study May 11, 2023 March 2028
NCT05868005 Recruiting N/A Delivering a Multi-disease Screening Tool to Migrant Populations October 23, 2023 September 2024
NCT02275221 Recruiting Immune Response in Patients With Hepatitis B and C Infection August 2013 December 2024
NCT05988879 Recruiting Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients August 2, 2023 August 2, 2028
NCT05330455 Recruiting Phase 2 Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection April 14, 2022 January 1, 2026
NCT04863703 Recruiting Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) May 7, 2021 December 31, 2024
NCT05304234 Recruiting Phase 2 Liver Cancer Disparities in American Indian and Alaska Native Persons April 1, 2022 September 1, 2026
NCT03933384 Recruiting Phase 4 Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B August 19, 2019 December 31, 2033
NCT06058390 Recruiting Phase 1 A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants October 4, 2023 May 15, 2024
NCT06084234 Recruiting Phase 4 National Liver Cancer Screening Trial December 26, 2023 December 31, 2034
NCT05272735 Recruiting Phase 4 HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers December 10, 2022 June 30, 2025
NCT05181826 Recruiting Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer May 21, 2019 December 2025
NCT03826433 Recruiting Phase 1 hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis October 1, 2018 December 31, 2024
NCT03825458 Recruiting Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. February 25, 2019 June 25, 2029
NCT04914611 Recruiting Real World Assessment of People Living With Chronic Hepatitis B in Australia February 17, 2022 July 1, 2027
NCT05144776 Recruiting Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool November 17, 2022 December 1, 2025
NCT05686759 Recruiting Phase 3 A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. January 18, 2023 September 2025
NCT05561673 Recruiting Phase 1 A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years October 4, 2022 January 2, 2025
NCT03771677 Recruiting N/A To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs. December 1, 2018 December 30, 2024
NCT05551273 Recruiting Phase 2 Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV May 5, 2023 July 17, 2025
NCT03692897 Recruiting An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection October 11, 2018 January 2026
NCT03640728 Recruiting The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure January 25, 2019 July 2023
NCT04954859 Recruiting Phase 2 Long-term Follow-up Study to Evaluate Durability of Sustained Virologic Response (SVR) in Previous GSK3228836 Study Participants (B-Sure) November 25, 2021 October 11, 2029
NCT05064553 Recruiting ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk July 26, 2021 April 2026
NCT04970836 Recruiting N/A The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort August 1, 2021 December 31, 2024
NCT00404989 Recruiting Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. January 1989 January 2099
NCT06160895 Recruiting Phase 1 A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects December 26, 2023 December 2024
NCT04568265 Recruiting Phase 2 A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B June 3, 2020 October 31, 2025
NCT04588077 Recruiting Phase 4 Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis September 14, 2020 July 1, 2024
NCT03025074 Recruiting Blood Collection Biorepository for Liver Disease Research July 2013 December 2099
NCT05786859 Recruiting Early Phase 1 The Efficacy and Safety of Rifaximin Treatment March 9, 2023 October 31, 2025
NCT04620226 Recruiting Phase 4 UHN Inpatient Hepatitis C & B Screening February 1, 2024 July 2025
NCT05839522 Recruiting Australian Hepatitis and Risk Survey in Prisons April 27, 2022 May 1, 2023
NCT00767936 Terminated Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma March 2008 September 2013
NCT00228592 Terminated Phase 2 HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection August 2005
NCT03032536 Terminated Phase 1 Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers January 31, 2017 June 28, 2017
NCT01369199 Terminated Phase 3 Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B May 2012 February 14, 2017
NCT03123159 Terminated Clinical Performance Evaluation of DxN HBV Assay May 27, 2014 August 30, 2017
NCT00305019 Terminated Phase 2 Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus July 2002 March 2004
NCT00313261 Terminated Phase 2 Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group June 2003 February 2005
NCT00313274 Terminated Phase 3 Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV July 2003 December 2004
NCT00313287 Terminated Phase 3 Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV June 2003 November 2004
NCT00120796 Terminated Phase 3 Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) August 2005 July 2008
NCT00316680 Terminated Phase 3 Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. March 2006 November 2006
NCT00362505 Terminated Phase 3 Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials June 2004 March 2006
NCT00362700 Terminated Phase 2 Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 July 2003 October 2005
NCT00376259 Terminated Phase 3 Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone January 2007
NCT01715987 Terminated Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment October 2012 May 2016
NCT03534141 Terminated N/A Mild Hypothermia and Acute Kidney Injury in Liver Transplantation July 7, 2018 September 14, 2023
NCT00412750 Terminated Phase 3 Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) December 2006 February 2009
NCT00496002 Terminated Phase 3 Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus August 2007
NCT00496158 Terminated Phase 3 Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus August 2007
NCT00498212 Terminated Phase 2 A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease July 2007 October 2008
NCT00524173 Terminated Phase 2 Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B August 29, 2007 February 16, 2017
NCT03932513 Terminated Phase 2 Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients April 11, 2019 December 21, 2019
NCT04023721 Terminated Phase 2 Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor June 18, 2019 July 16, 2020
NCT04059198 Terminated Phase 2 Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus October 10, 2019 April 2, 2020
NCT02288208 Terminated Phase 1 Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B November 2014 May 2015
NCT00768001 Terminated Genetic Analysis of Liver Cancer June 2008 October 2011
NCT02479880 Terminated Phase 4 Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection July 3, 2015 April 11, 2018
NCT00871741 Terminated Phase 2 Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. April 1, 2009 June 25, 2009
NCT02577029 Terminated Phase 2 Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) December 2015 December 2016
NCT02604199 Terminated Phase 2 A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection September 2015 January 2017
NCT02604212 Terminated Phase 2 A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection November 2015 December 2016
NCT02738008 Terminated Phase 2 Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection March 2016 December 2016
NCT00158704 Terminated N/A Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. January 2002 January 2005
NCT02797522 Terminated Phase 1 A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) June 2016 November 2016
NCT02826018 Terminated Phase 1 A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection June 24, 2016 October 2017
NCT04540653 Unknown status Phase 4 Immunogenicity of the Hepatitis B Vaccine July 29, 2017 March 31, 2022
NCT05086536 Unknown status Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis October 15, 2021 December 30, 2022
NCT00451984 Unknown status Phase 3 Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 March 2007
NCT05094869 Unknown status Prevention of HCC Using Mobile Phone Applications November 15, 2021 December 31, 2023
NCT03604016 Unknown status Phase 4 Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver September 23, 2018 July 30, 2020
NCT01765231 Unknown status Phase 4 Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma January 2013 December 2017
NCT03625934 Unknown status Phase 2 Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 August 6, 2018 December 31, 2023
NCT00489151 Unknown status N/A A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy June 2005 December 2007
NCT01732081 Unknown status "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection January 2011 January 2021
NCT02799316 Unknown status N/A Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies? June 2016 January 2018
NCT04326803 Unknown status Phase 4 Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response June 1, 2020 December 30, 2023
NCT03680183 Unknown status Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) May 22, 2018 December 31, 2021
NCT01933412 Unknown status Phase 3 Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients March 2012
NCT01720238 Unknown status Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis March 2012 December 2018
NCT00044135 Unknown status Phase 2 A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus. August 2002
NCT01973582 Unknown status Hepatitis B Seroepidemiology Among Young Adults July 2011 December 2014
NCT03798119 Unknown status Phase 4 TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) February 25, 2019 August 31, 2021
NCT01987791 Unknown status Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis January 2005
NCT03801798 Unknown status Phase 2 A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients February 11, 2019 December 2021
NCT01998620 Unknown status Phase 4 Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis November 2013 May 2015
NCT03396458 Unknown status Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg September 1, 2017 August 31, 2020
NCT01610115 Unknown status HBV DNA Levels During Pregnancy in Chronic Hepatitis B January 2012 December 2014
NCT01599130 Unknown status N/A Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss July 2012 April 2014
NCT03362866 Unknown status Epidemiology of Hepatitis B, C and Delta in Reunion Island January 2019 April 2023
NCT03919565 Unknown status N/A Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis February 1, 2019 December 31, 2021
NCT03920605 Unknown status N/A Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis February 1, 2019 December 31, 2021
NCT03920618 Unknown status N/A Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF February 1, 2019 December 31, 2023
NCT00154531 Unknown status Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI August 2004 May 2005
NCT04386915 Unknown status Phase 1 Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets May 18, 2020 August 1, 2021
NCT03341195 Unknown status N/A Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan January 2018 September 2018
NCT03957629 Unknown status N/A Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis November 6, 2019 July 30, 2023
NCT03973502 Unknown status N/A Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD June 12, 2017 May 31, 2023
NCT01548326 Unknown status Phase 4 Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine September 2011 July 2012
NCT02148562 Unknown status Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity April 2014 December 2017
NCT02764671 Unknown status Phase 4 Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates May 2015 September 2020
NCT04056728 Unknown status Phase 4 A Phase IV Study to Assess the Safety of EupentaTM Inj September 23, 2019 December 31, 2020
NCT02186574 Unknown status Phase 3 Tenofovir to Prevent HBV Reactivation May 2015 February 2021
NCT04073459 Unknown status Phase 2 Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants November 2019 August 2020
NCT05390424 Unknown status N/A Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot June 2022 September 2023
NCT02257645 Unknown status Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks March 2015 September 2016
NCT01462981 Unknown status Cohort of Hepatitis B Research of Amsterdam September 2011 July 2012
NCT04499443 Unknown status Phase 1 Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets August 18, 2020 May 31, 2021
NCT03219203 Unknown status Phase 4 Immunologic Response of Hepatitis B Vaccine July 1, 2017 October 1, 2018
NCT03123653 Unknown status N/A To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy. March 17, 2017 September 17, 2020
NCT02331745 Unknown status Phase 4 RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure October 2013 October 2016
NCT00160940 Unknown status Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis February 2002
NCT00702663 Unknown status Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults October 2007 October 2008
NCT01451801 Unknown status Phase 4 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders October 2011 July 2013
NCT00720668 Unknown status The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma June 2006 May 2010
NCT01441609 Unknown status Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination August 2011 May 2012
NCT02417207 Unknown status Phase 4 Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation April 2015 April 2018
NCT04625166 Unknown status Combi-elastography Assessment of Chronic Liver Disease Multi-center Study December 1, 2020 June 30, 2022
NCT00753467 Unknown status Phase 2 A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B September 2008 August 2009
NCT03084250 Unknown status Phase 4 The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC March 10, 2017 December 1, 2023
NCT00147459 Unknown status N/A Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation September 2005 December 2012
NCT00188240 Unknown status N/A Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy August 2003
NCT02889094 Unknown status French HIV-HBV Cohort October 2016 September 2018
NCT04195282 Unknown status N/A RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF December 2019 December 2021
NCT04196998 Unknown status N/A Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis January 1, 2019 December 2023
NCT01139203 Unknown status N/A Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation August 2009
NCT03027258 Unknown status N/A Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome September 2016 January 2018
NCT00822991 Unknown status N/A Sonazoid Enhanced Liver Cancer Trial for Early Detection January 2009 December 2019
NCT04202536 Unknown status Phase 4 Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate May 29, 2019 October 2021
NCT00845403 Unknown status Antigen-specific Immune Response to Hepatitis B Virus in Utero September 2008 December 2016
NCT04431375 Unknown status N/A Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV June 22, 2020 June 10, 2022
NCT00877357 Unknown status Phase 4 Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine January 2009 February 2013
NCT01344174 Unknown status N/A A Study Evaluating the Efficacy of Glucocorticoids in Patients With Pre-ACLF-HBV May 2011 November 2013
NCT00188201 Unknown status Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication January 2002
NCT01341743 Unknown status Phase 4 Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy December 2010 December 2014
NCT00155103 Unknown status Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma August 2004
NCT00932269 Unknown status Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease March 2007 September 2011
NCT04525833 Unknown status Liver Disease and Other Systemic Diseases January 1, 2020 December 31, 2021
NCT04294433 Unknown status Phase 3 Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children June 11, 2018 December 30, 2023
NCT02644538 Unknown status Phase 4 Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides December 2015 December 2018
NCT01341275 Unknown status Phase 4 Adolescents' Response to Hepatitis B Vaccine Booster Dose April 2010 November 2011
NCT02687061 Unknown status Chronic Hepatitis B and C Recall Northern Holland February 2016 December 2016
NCT02982837 Unknown status Phase 4 To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B March 2015 May 2019
NCT02959684 Unknown status Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France April 14, 2017 July 2019
NCT04310787 Unknown status Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure May 15, 2020 December 15, 2022
NCT02957994 Unknown status Phase 4 TAF Switch Study in Hepatitis B Monoinfection December 22, 2016 November 1, 2017
NCT00152880 Unknown status Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative July 2005
NCT00172328 Unknown status N/A Antibody Response and Immune Memory 15-18 Years After HBV Vaccination
NCT04998838 Unknown status N/A Stop Hep B @ Birth July 1, 2018 June 30, 2023
NCT03566030 Unknown status Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance September 1, 2018 August 31, 2020
NCT01768195 Unknown status Phase 4 Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy January 2013 December 2017
NCT03568578 Unknown status N/A A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers January 28, 2018 September 30, 2021
NCT04959643 Unknown status Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital October 5, 2021 October 2023
NCT01727271 Withdrawn Phase 4 A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384) August 2013 August 2017
NCT04289428 Withdrawn Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays January 2022 October 2022
NCT02605538 Withdrawn N/A Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively September 1, 2015 December 31, 2025
NCT03829735 Withdrawn N/A Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal November 1, 2020 August 30, 2021
NCT00051090 Withdrawn N/A Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV
NCT01645007 Withdrawn Prevalence of Hepatitis B Infection in the Galilee Region, Israel
NCT04843852 Withdrawn Phase 1 TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B July 2022 July 2024
NCT00782301 Withdrawn Phase 4 Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients March 2009 February 2010
NCT00051077 Withdrawn Phase 2 Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
NCT02135666 Withdrawn Phase 4 Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) May 2015 October 2019
NCT01126853 Withdrawn Phase 4 Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders April 2010 July 2011
Disase is a (Disease Ontology)
DOID:934
Cross Reference ID (Disease Ontology)
EFO:0004197
Cross Reference ID (Disease Ontology)
MESH:D006509
Cross Reference ID (Disease Ontology)
NCI:C3097
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:66071002
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0019163
Exact Synonym (Disease Ontology)
chronic hepatitis B
Exact Synonym (Disease Ontology)
hepatitis B infection
Disase Synonym (Disease Ontology)
Serum hepatitis
MeSH unique ID (MeSH (Medical Subject Headings))
D006509